Status:
COMPLETED
Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Qingkepingchuan Granules Clinical Observation of Phlegm-Heat and Lung Depletion
Lead Sponsor:
Zhang Zhijie
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40-90 years
Phase:
NA
Brief Summary
Through the clinical observation of Qingcheng Pingxian Granules in the treatment of acute exacerbation of chronic obstructive pulmonary disease (phlegm-heat lung syndrome), (1) to evaluate the safety ...
Eligibility Criteria
Inclusion
- Meet the diagnostic criteria of AECOPD.
- Chinese medicine diagnosis is consistent with phlegm-heat and lung depletion evidence
- 40 years old ≤ age ≤ 90 years old
- Patients who signed the informed consent form and volunteered to participate in the study
Exclusion
- Combined with other primary lung diseases such as bronchial asthma, bronchiectasis, etc.
- Combination of serious cardiovascular, urinary, digestive, haematopoietic, endocrine metabolic system diseases, other psychiatric and neurological diseases.
- Pregnant or lactating patients.
- Allergic to the clinical trial drugs.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06143358
Start Date
January 1 2022
End Date
July 7 2023
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing University of Chinese Medicine
Beijing, China